1. 297 IDENTIFICATION OF NOVEL ALTERED PEPTIDE LIGANDS RECOGNIZED BY HUMAN TUMOR-REACTIVE T CELLS. (1st January 2006) Authors: Fallahi, A.; Li, Y.; Pinilla, C.; Yee, C. Journal: Journal of investigative medicine Issue: Volume 54:Number 1(2006) Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 50 IDENTIFICATION OF NOVEL ALTERED PEPTIDE LIGANDS RECOGNIZED BY HUMAN TUMOR-REACTIVE T CELLS. (1st January 2006) Authors: Fallahi, A.; Li, Y.; Pinilla, C.; Yee, C. Journal: Journal of investigative medicine Issue: Volume 54:Number 1(2006) Page Start: S88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 517 Long-term efficacy of intrathecal interleukin-2 (IT IL2) in metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD). (September 2015) Authors: Glitza, I.C.; Rohlfs, M.L.; Bassett, R.; John, I.; Richard, J.; Iqbal, M.; Bernzen, T.; Gerber, D.L.; Lacey, C.; Diab, A.; Amaria, R.N.; Woodman, S.E.; Patel, S.P.; Yee, C.; Hwu, W.J.; Hwu, P.; Papadopoulos, N.; Davies, M.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhancing departmental preparedness for COVID-19 using rapid-cycle in-situ simulation. Issue 4 (August 2020) Authors: Dharamsi, A.; Hayman, K.; Yi, S.; Chow, R.; Yee, C.; Gaylord, E.; Tawadrous, D.; Chartier, L.B.; Landes, M. Journal: Journal of hospital infection Issue: Volume 105:Issue 4(2020) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. (23rd June 2022) Authors: Wong, R.; Fishman, J.; Wilson, K.; Yeh, M.; Hakimi, Z.; Yee, C.; Huynh, L.; Duh, M. S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to: The Survival Time of 8376 Male Breast Cancer Patients. Issue 12 (December 2018) Authors: Wan, B.A.; Ganesh, V.; Zhang, L.; Sousa, P.; Drost, L.; Lorentz, J.; Vesprini, D.; Lee, J.; Rakovitch, E.; Lu, F.-I.; Eisen, A.; Yee, C.; Lam, H.; Chow, E. Journal: Clinical oncology Issue: Volume 30:Issue 12(2018) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients. Issue 6 (June 2018) Authors: Wan, B.A.; Ganesh, V.; Zhang, L.; Sousa, P.; Drost, L.; Lorentz, J.; Vesprini, D.; Lee, J.; Rakovitch, E.; Lu, F.-I.; Eisen, A.; Yee, C.; Lam, H.; Chow, E. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Trends and Correlates of Mean Lung Dose in Patients Receiving Breast Radiotherapy in a Single Institution from 2014 to 2018. Issue 10 (October 2020) Authors: McKenzie, E.; Razvi, Y.; Wronski, M.; Zhang, L.; Bosnic, S.; Vesprini, D.; Paszat, L.; Rakovitch, E.; Drost, L.; Yee, C.; Russell, S.; McCann, C.; Chow, E. Journal: Clinical oncology Issue: Volume 32:Issue 10(2020) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗